WO2013190542A3 - Compositions topiques pour le traitement de maladies inflammatoires chroniques de la peau - Google Patents

Compositions topiques pour le traitement de maladies inflammatoires chroniques de la peau Download PDF

Info

Publication number
WO2013190542A3
WO2013190542A3 PCT/IL2013/050497 IL2013050497W WO2013190542A3 WO 2013190542 A3 WO2013190542 A3 WO 2013190542A3 IL 2013050497 W IL2013050497 W IL 2013050497W WO 2013190542 A3 WO2013190542 A3 WO 2013190542A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
chronic inflammatory
skin disease
topical compositions
inflammatory skin
Prior art date
Application number
PCT/IL2013/050497
Other languages
English (en)
Other versions
WO2013190542A2 (fr
Inventor
Sharon ROZENBLAT
Original Assignee
Kamedis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kamedis Ltd filed Critical Kamedis Ltd
Publication of WO2013190542A2 publication Critical patent/WO2013190542A2/fr
Publication of WO2013190542A3 publication Critical patent/WO2013190542A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

Une composition topique comprenant une combinaison d'extrait de fruit de Sapindus mukurossi, d'huile de graines de Taraktogenos kurzii, d'extrait de Portulaca oleracea, avec de l'allantoïne ou de la glycérine ou une combinaison de celles-ci, et un véhicule cosmétiquement ou dermatologiquement acceptable.
PCT/IL2013/050497 2012-06-17 2013-06-10 Compositions topiques pour le traitement de maladies inflammatoires chroniques de la peau WO2013190542A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261660746P 2012-06-17 2012-06-17
US61/660,746 2012-06-17

Publications (2)

Publication Number Publication Date
WO2013190542A2 WO2013190542A2 (fr) 2013-12-27
WO2013190542A3 true WO2013190542A3 (fr) 2015-06-25

Family

ID=49769632

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2013/050497 WO2013190542A2 (fr) 2012-06-17 2013-06-10 Compositions topiques pour le traitement de maladies inflammatoires chroniques de la peau

Country Status (1)

Country Link
WO (1) WO2013190542A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017048804A1 (fr) * 2015-09-14 2017-03-23 Melaleuca, Inc. Compositions de soins cutanés
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
JP2019510036A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティクス／プレバイオティクス有効成分を含む清浄剤組成物
CA3043748A1 (fr) 2016-11-23 2018-05-31 Gojo Industries, Inc. Composition desinfectante comprenant une substance active probiotique/prebiotique
CN111685131B (zh) * 2020-06-15 2021-06-29 山东省农业科学院植物保护研究所 一种利用马齿苋提取物预防花生锈病的药物组合物及其制备方法

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020176903A1 (en) * 1999-10-14 2002-11-28 Noriyasu Kuno Skin-beautifying agent, anti-aging agent for the skin, whitening agent and external agent for the skin
US20030133958A1 (en) * 2000-03-31 2003-07-17 Noriyasu Kuno External agent for the skin and whitening agent
US20040126352A1 (en) * 2002-12-31 2004-07-01 Jones Brian C. Use of purslane to treat facial wrinkles
US20060078633A1 (en) * 2002-12-27 2006-04-13 Na Min K Extract of cercis chinensis having anti-oxidant activity and anti-aging activity, and cosmetical composition containing the extract for anti-oxidation, skin-aging protection and wrinkle improvement
US20070140984A1 (en) * 2004-03-17 2007-06-21 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Functional powdery product
US20080193393A1 (en) * 2004-09-24 2008-08-14 Lipo Chemicals Inc. Delivery System for Topically Applied Compounds
US20110020477A1 (en) * 2008-03-31 2011-01-27 Shiseido Company, Ltd. Oral preparation, injection preparation, external skin preparation and cosmetic method for preventing or improving wrinkles
US20110129453A1 (en) * 2009-12-02 2011-06-02 Bath & Body Works Brand Management, Inc. Topical skin composition and method for moisturizing the skin
US20110256249A1 (en) * 2010-04-16 2011-10-20 Doreen Campbell Hair and scalp care formulations for treating and preventing acne and related skin conditions
WO2012077120A2 (fr) * 2010-12-09 2012-06-14 Y&B Mother's Choice Ltd. Formulations naturelles
DE102010055252A1 (de) * 2010-12-20 2012-06-21 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Verfahren zur Entwicklung einer als Schaum auf die Haut zu applizierende flüssige Zusammensetzung sowie eine topisch applizierbare Zusammensetzung
WO2012090205A2 (fr) * 2010-12-28 2012-07-05 Kamedis Ltd. Extraits végétaux pour le traitement et la prévention d'infections
US20120230926A1 (en) * 2011-03-08 2012-09-13 Corstjens Hugo A Method For Cosmetically Treating Caspase-14 Deficiency
CN102743635A (zh) * 2012-06-24 2012-10-24 宋敏 一种治疗嗜食芥茉型蜂窝组织炎的中药洗剂制备方法

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020176903A1 (en) * 1999-10-14 2002-11-28 Noriyasu Kuno Skin-beautifying agent, anti-aging agent for the skin, whitening agent and external agent for the skin
US20030133958A1 (en) * 2000-03-31 2003-07-17 Noriyasu Kuno External agent for the skin and whitening agent
US20060078633A1 (en) * 2002-12-27 2006-04-13 Na Min K Extract of cercis chinensis having anti-oxidant activity and anti-aging activity, and cosmetical composition containing the extract for anti-oxidation, skin-aging protection and wrinkle improvement
US20040126352A1 (en) * 2002-12-31 2004-07-01 Jones Brian C. Use of purslane to treat facial wrinkles
US20070140984A1 (en) * 2004-03-17 2007-06-21 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Functional powdery product
US20080193393A1 (en) * 2004-09-24 2008-08-14 Lipo Chemicals Inc. Delivery System for Topically Applied Compounds
US20110020477A1 (en) * 2008-03-31 2011-01-27 Shiseido Company, Ltd. Oral preparation, injection preparation, external skin preparation and cosmetic method for preventing or improving wrinkles
US20110129453A1 (en) * 2009-12-02 2011-06-02 Bath & Body Works Brand Management, Inc. Topical skin composition and method for moisturizing the skin
US20110256249A1 (en) * 2010-04-16 2011-10-20 Doreen Campbell Hair and scalp care formulations for treating and preventing acne and related skin conditions
WO2012077120A2 (fr) * 2010-12-09 2012-06-14 Y&B Mother's Choice Ltd. Formulations naturelles
DE102010055252A1 (de) * 2010-12-20 2012-06-21 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Verfahren zur Entwicklung einer als Schaum auf die Haut zu applizierende flüssige Zusammensetzung sowie eine topisch applizierbare Zusammensetzung
WO2012090205A2 (fr) * 2010-12-28 2012-07-05 Kamedis Ltd. Extraits végétaux pour le traitement et la prévention d'infections
US20120230926A1 (en) * 2011-03-08 2012-09-13 Corstjens Hugo A Method For Cosmetically Treating Caspase-14 Deficiency
CN102743635A (zh) * 2012-06-24 2012-10-24 宋敏 一种治疗嗜食芥茉型蜂窝组织炎的中药洗剂制备方法

Also Published As

Publication number Publication date
WO2013190542A2 (fr) 2013-12-27

Similar Documents

Publication Publication Date Title
CA2894892A1 (fr) Derives d'acide boronique et leurs utilisations therapeutiques
WO2014188276A3 (fr) Compositions d'antioxydants et procédés d'utilisation
WO2014108846A3 (fr) Composition cosmétique apaisante basée sur de l'acide salicylique
WO2012143576A3 (fr) Composés pour prévenir, réduire et/ou soulager des états de démangeaison de la peau
CA2894891A1 (fr) Derives d'acide boronique et leurs utilisations therapeutiques
WO2011107462A3 (fr) Compositions de protection solaire
UY35115A (es) Imidazo[1,2-a]piridincarboxamidas aminosustituidas y su uso
MX2015003239A (es) Composiciones topicas y metodos de uso.
AU2014359194A1 (en) Lipid microcapsules preferably comprising a retinoid, and composition containing same, method for the production thereof, and use thereof in dermatology
WO2011117377A3 (fr) Méthodes et compositions améliorées pour le traitement sûr et efficace de l'érythème
MX2013005995A (es) Composicion topica que promueve la melanina.
WO2014043230A3 (fr) Formulations comprenant de l'idébénone, de la n-acétyl-s-farnésyl-l-cystéine et de l'ergothionéine et leurs utilisations
WO2010092088A3 (fr) Utilisation d'hydrophobine en tant qu'agent mouillant
WO2013190542A3 (fr) Compositions topiques pour le traitement de maladies inflammatoires chroniques de la peau
WO2011117378A3 (fr) Methodes et compositions ameliorées pour le traitement sûr et efficace de la télangiectasie
RU2014130012A (ru) Композиции, содержащие экстракт malva neglecta
WO2013081778A3 (fr) Composés nitrones et leur utilisation dans le soin personnel
MX2014014517A (es) Composiciones topicas bajo la forma de un gel que contiene un retinoide particular solubilizado.
MY160377A (en) Topical pharmaceutical compositions
MX2014014579A (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
IT1401289B1 (it) Composti dotati di attivita' antiossidante nei confronti dei radicali liberi, e composizioni farmaceutiche e cosmetiche che li contengono
WO2014133811A3 (fr) Composés dérivés de plantes salvinia invasives et leurs procédés d'utilisation
WO2014031982A3 (fr) Méthodes et compositions pour le traitement de la douleur
WO2013068962A3 (fr) Acide gras monoinsaturé pour le soin des ongles
WO2012108747A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait de la racine d'helena

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13807857

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13807857

Country of ref document: EP

Kind code of ref document: A2